- Atlas Sexual Enhancement Products Recalled: FDA
- FDA Opens Mexico City Office
- Fewer U.S. Seniors Hospitalized for Preventable Conditions
Here are some of the latest health and medical news developments, compiled by the editors of HealthDay:
Atlas Sexual Enhancement Products Recalled: FDA
Various brands of sexual enhancement dietary supplements made by Atlas Operations Inc. of Florida have been recalled because they contain an ingredient that might pose a health threat, says the U.S. Food and Drug Administration.
The agency said lab tests found that the products "contain Sulfoaildenafil, an analogue of Sildenafil, an FDA-approved drug used as treatment for male erectile dysfunction, making these products an unapproved drug. The active drug ingredient is not listed on the product label," United Press International reported.
The undeclared ingredient may interact with some prescription drugs and lower blood pressure to dangerous levels, the FDA warned.
The voluntary recall includes dietary supplement capsules sold under the names Aspire One, Sex Enhancer, Staminil, Sexual Surge, Love Fuel, Vaxitrol, Love Fuel 2, Erexa, Zenerect, Arousin, 72 Hours, Enhancement, Red Hot Sex, Libiplus, Erexxx, Tacktol, Amour for Him, Erousa, Rockhard, Ezerex, Topviril, Vierect, APL, Clyamax, Rainbow Rocket, Finally on Demand, Xtremexcite, Whatzup and Depth Charge. The products' lot numbers are 494, 520C, 520B, 520A, 520, 521, 705, 706, 779 and 807.
Consumers can return the dietary supplements for a refund or get more information by calling Atlas Operations at 800-466-4444, UPI reported.
FDA Opens Mexico City Office
A Mexico City office opened this week by the U.S. Food and Drug Administration is the agency's 10th international post in a program meant to improve the safety of food and medical products imported into the United States.
FDA staff at the Mexico City post will work with counterparts in the Mexican government on a number of initiatives, including harmonization of regulations and guidance standards, collaboration on the use of the latest laboratory techniques, and joint training on food-borne illness and food oversight.
In addition, FDA experts will educate Mexican industries that ship food and medical products north of the border about U.S. safety and product quality expectations.
"The opening of this office represents an important step as we re-design our product safety strategy. We, like our partners in the Mexican Government, realize that prevention is the key. For example, more than a third of the fresh fruits and vegetables we eat come from Mexico as do a large amount of our medical devices. Having FDA experts located permanently there will be mutually beneficial to both our countries and respective citizens," FDA Commissioner Dr. Margaret A. Hamburg said in an agency news release.
The FDA's other posts include China, India, Europe, Chile and Costa Rica.
Fewer U.S. Seniors Hospitalized for Preventable Conditions
Between 2003 and 2007, many fewer U.S. seniors age 65 and older were hospitalized for potentially preventable conditions, such as angina, pneumonia and uncontrolled diabetes, says a federal government report.
Patients ages 18 to 64 had less of a decrease in the 11 chronic and acute conditions that can usually be controlled outside the hospital if patients have access to good outpatient care and follow doctors' instructions, said the latest News and Numbers from the Agency for Healthcare Research and Quality.
Here are the conditions and the rates of declines for older and younger patients:
- Angina -- 43 percent vs. 39 percent.
- Uncontrolled diabetes -- 21 percent vs. 5 percent.
- Dehydration -- 20 percent vs. 16 percent.
- Short-term diabetes complications, such as hypoglycemia -- 19 percent decline vs. an increase of 10 percent.
- Amputation of the feet or legs, usually because of diabetes -- 17 percent vs. 3 percent.
- Bacterial pneumonia -- 16 percent vs. 8 percent.
- Congestive heart failure -- 14 percent vs. 9 percent.
Rates of hospitalization for high blood pressure increased at roughly the same for older and younger patients, while rates of hospitalization for urinary tract infections increased by 15 percent for older patients and by 1 percent for younger patients.
Copyright © 2011 HealthDay. All rights reserved.